One would assume on recent presentations and forward looking ambition that this company now actually has a plan where it once looked like they were muddling through any type of plan at all. Looks more like a re-rate on the possibility of an awarded PRL. 18-20c wouldn't surprise me with more interest from retail investors.
- Forums
- ASX - By Stock
- NRZ
- Ann: Pre-Feasibility Study Presentation
Ann: Pre-Feasibility Study Presentation, page-33
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NRZ (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $8.724M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
NRZ (ASX) Chart |
Day chart unavailable
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, MD & CEO
James Graham
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online